Every 424B that Aditxt Inc (ADTX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow ADTX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ADTX filings page.
Aditxt, Inc. filed a prospectus to register up to 148,278,241 shares of Common Stock for resale by selling stockholders, representing shares issuable upon exercise of outstanding warrants. The filing states the warrants have a $0.50 exercise price (Adjustment Price as of the April 7, 2026 adjustment) and that if all warrants were exercised for cash it would yield gross proceeds of approximately $74.14 million to the company. The prospectus confirms the company will not receive proceeds from resale by the selling stockholders; proceeds to the company would arise only if warrants are exercised for cash. The resale program covers multiple warrant series and placement-agent warrants, and includes a 4.99% beneficial ownership limit on warrant exercises (adjustable to 9.99% upon notice). The filing notes Nasdaq listing under the symbol ADTX and a closing share price of $0.347 on April 20, 2026.
ADTX amends its shelf to increase its ATM capacity to $53,398,964. This prospectus supplement adds $36,800,000 of new ATM capacity, bringing the aggregate authorized amount under the sales agreement to $53,398,964, and leaves prior terms and the sales agreement unchanged.
The supplement states the company has previously sold approximately 398,950 shares for aggregate gross proceeds of $21,257,000, leaving about $16,500,000 of prior capacity before this increase. The filing also discloses the last reported Nasdaq sale price of the common stock was $0.81 per share as of March 27, 2026.
The company filed a prospectus supplement to increase the capacity of its at-the-market common stock offering to up to $20,000,000 in aggregate gross sales, not including shares previously sold, under its existing agreement with H.C. Wainwright & Co., LLC as sales agent.
Previously, the company had registered up to $35,000,000 of common stock for sales under this program, later reduced to $11,840,454, and it has already sold 1,370,607 shares for aggregate gross proceeds of $17,771,951 under prior prospectus supplements. The supplement also notes that the company is currently no longer subject to the offering limits in General Instruction I.B.6 of Form S-3, and that its common stock trades on the Nasdaq Capital Market under the symbol ADTX, where the last reported sale price was $2.24 per share on December 12, 2025.